Robotic Hysterectomy for Benign Gynecology: Evidence and Insights
review
OA: closed
public-domain-us
⚙
AI-generated summary
by claude@2026-06, 2026-06-08
ⓘ
This review evaluates factors like quality of life, cost, and surgical complexity to determine the benefits and drawbacks of robotic hysterectomy compared to laparoscopic hysterectomy for benign gynecologic conditions.
⚙
AI-generated deep summary
by claude@2026-06, 2026-06-13
· read from full text
ⓘ
This paper is a review that evaluates evidence and considerations comparing robotic hysterectomy (RH) versus laparoscopic hysterectomy (LH) and abdominal hysterectomy (AH) for benign gynecologic diseases, including uterine myoma, adenomyosis, endometriosis, and genital prolapse. It discusses that RH is increasingly used for complex cases where LH or vaginal hysterectomy are contraindicated, while noting that both RH and LH have low complication rates and that the added benefits of RH over LH remain debated; it frames multiple outcomes and feasibility factors used in the literature, such as quality of life, cost, uterine size, complex pathology, obesity, and surgeon experience, without claiming a definitive advantage. As a review, a key limitation is that it synthesizes heterogeneous evidence across studies rather than providing new comparative trial results. Relevance to endometriosis: the paper explicitly lists endometriosis among the benign gynecologic indications for hysterectomy and discusses RH as an approach applied to such conditions when less invasive options are unsuitable, though the paper’s main focus is comparative evidence and decision factors for RH versus LH across benign gynecologic disease.
Abstract
Hysterectomy is the regimen of choice for benign gynecologic diseases, including uterine myoma, adenomyosis, endometriosis, and genital prolapse. Surgeons choose hysterectomy methods based on clinical situations or patients' preferences. Even though minimal invasive surgery (MIS) such as robotic hysterectomy (RH) and laparoscopic hysterectomy (LH) has been improved, the abdominal hysterectomy (AH) approach is still the most common. The advancement in robotic surgeries results in increased adoption of MIS. It allows the surgeon to perform a hysterectomy for complex cases where LH and vaginal hysterectomy are contraindicated and would otherwise require laparotomy. Since both LH and RH have low rates of complications, it is not clear what benefits RH offers over LH. So, RH's advantages over LH are being debated. Robotic gynecologic treatment may have benefits that are hard to quantify. In the literature, different factors such as quality of life, cost, uterine size, complex pathology, obesity, and surgeon's experience, are being used to know the feasibility of RH. Therefore, in this review, we evaluate the factors that can help conclude the benefits or drawbacks of RH and LH.
Full text
2,024 characters
· extracted from
oa-doi-fallback
· click to expand
Hysterectomy is the regimen of choice for benign gynecologic diseases, including uterine myoma, adenomyosis, endometriosis, and genital prolapse. Surgeons choose hysterectomy methods based on clinical situations or patients’ preferences. Even though minimal invasive surgery (MIS) such as robotic hysterectomy (RH) and laparoscopic hysterectomy (LH) has been improved, the abdominal hysterectomy (AH) approach is still the most common. The advancement in robotic surgeries results in increased adoption of MIS. It allows the surgeon to perform a hysterectomy for complex cases where LH and vaginal hysterectomy are contraindicated and would otherwise require laparotomy. Since both LH and RH have low rates of complications, it is not clear what benefits RH offers over LH. So, RH’s advantages over LH are being debated. Robotic gynecologic treatment may have benefits that are hard to quantify. In the literature, different factors such as quality of life, cost, uterine size, complex pathology, obesity, and surgeon’s experience, are being used to know the feasibility of RH. Therefore, in this review, we evaluate the factors that can help conclude the benefits or drawbacks of RH and LH.
Robotic Hysterectomy for Benign Gynecology
Evidence and Insights
Plain Language SummaryHysterectomy is a common procedure for treating benign gynecologic conditions like uterine myoma and endometriosis. While minimally invasive surgeries (MIS) such as robotic hysterectomy (RH) and laparoscopic hysterectomy (LH) are advancing, abdominal hysterectomy (AH) remains prevalent. RH is increasingly adopted for complex cases unsuitable for LH or vaginal hysterectomy. Both RH and LH have low complication rates, but the specific advantages of RH over LH are debated. Factors like quality of life, cost, uterine size, complex pathology, obesity, and surgeon experience are considered to assess RH's feasibility. This review examines these factors to evaluate RH and LH benefits.
Text is machine generated and may contain inaccuracies. FAQ
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.
My notes (saved in your browser only)
⚙
Ask this paper
AI returns verbatim quotes from the full text
· source: oa-doi-fallback
ⓘ
Condition tags
endometriosisadenomyosis
MeSH descriptors
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Genital Diseases, Female
Citation neighborhood
(no data yet)
We don't have any in-corpus citations linked to this paper yet.
This is a recent paper (2026) — citers
typically take a year or two to land, and the OpenAlex reference
graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-08-01T06:07:04.264727+00:00
- pubmed
- last seen: 2026-08-01T06:02:47.465692+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine